About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Ovarian Cancer Relapse Delayed, Thanks to a New Drug

by Dr. Enozia Vakil on June 2, 2013 at 10:46 PM
Font : A-A+

 Ovarian Cancer Relapse Delayed, Thanks to a New Drug

A drug, originally used to treat kidney cancer, may prove to be effective in delaying the relapse of ovarian cancer, a clinical study recently revealed.

About 70 percent of patients with advanced ovarian cancer experience a relapse following surgery and chemotherapy and need to resume aggressive treatments. The deadly disease's cure rate is just 20 to 25 percent.

Advertisement

German researchers found that the GlaxoSmithKlein drug pazopanib (Votrient) extended the median time to disease worsening to 17.9 months compared with 12.3 months for patients given a placebo in a phase III clinical trial.

"Our findings show that we finally have a drug that can maintain control over ovarian cancer growth achieved through initial treatments," said lead author Andreas du Bois, a professor of gynecologic oncology at Kliniken Essen Mitte in Germany.
Advertisement

"If pazopanib is approved for ovarian cancer, many patients will experience longer disease-free and chemotherapy-free periods. During this time, the patient keeps control over the disease instead of the disease having control over the patient's life."

An estimated 22,240 new cases of ovarian cancer are expected to be detected in the United States in 2013, and 14,030 women are expected to die from the disease this year.

There are currently no drugs approved in the United States as maintenance therapies for patients who've undergone treatment for advanced ovarian cancer, although Europe has approved Genentech's bevacizumab (Avastin) for that use.

Pazopanib is an oral drug that blocks several targets involved in the growth of tumors and their blood vessels.

The study was presented at the annual meeting of the American Society of Clinical Oncology (ASCO.)

"Relapses remain all too common for women with advanced ovarian cancer," said Carol Aghajanian, an ASCO spokeswoman and gynecologic cancers expert.

"This large trial shows us that targeting multiple molecular cancer drivers can have a substantial impact on this cancer's ability to grow, giving our patients significantly longer time before relapse."

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Ovarian Cancer Cancer and Homeopathy Clinical Trials - Different Phases of the trial Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Meigs Syndrome Ovarian Pain 

Recommended Reading
New Novel Approach to Treat Ovarian Cancer
A novel, targeted approach to chemotherapy that makes ovarian cancer cells more susceptible to the ....
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Meigs Syndrome
Meigs'' syndrome is a medical condition with a triad of symptoms including benign ovarian tumor, asc...
Ovarian Cancer
Ovarian cancer affects both the ovaries and is referred to as the ''silent killer'' as the symptoms ...
Ovarian Pain
Ovarian pain is caused due to various conditions like ovarian cysts, ovarian tumors, endometriosis, ...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use